We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

151 hedge funds and large institutions have $396M invested in Sciclone Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $210K | Put options by funds: $136K

35% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 46

0% more funds holding

Funds holding: 151151 (0)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

24% less capital invested

Capital invested by funds: $521M → $396M (-$124M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
151
Holders Change
Holders Change %
0%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
22
Increased
62
Reduced
46
Closed
22
Calls
$210K
Puts
$136K
Net Calls
+$74K
Net Calls Change
-$1.21M
Name Holding Trade Value Shares
Change
Change in
Stake
LSERS
101
Louisiana State Employees Retirement System
Louisiana
$227K
Capital Fund Management (CFM)
102
Capital Fund Management (CFM)
France
$222K +$236K +21,700 New
Nisa Investment Advisors
103
Nisa Investment Advisors
Missouri
$215K +$218K +20,000 +2,000%
Wells Fargo
104
Wells Fargo
California
$206K -$2.92K -268 -1%
PCM
105
Prelude Capital Management
New York
$204K +$156K +14,300 +255%
Macquarie Group
106
Macquarie Group
Australia
$201K -$993K -91,200 -82%
Public Employees Retirement Association of Colorado
107
Public Employees Retirement Association of Colorado
Colorado
$198K
AL
108
Airain Ltd
Guernsey
$184K +$195K +17,905 New
TRSOTSOK
109
Teachers Retirement System of the State of Kentucky
Kentucky
$182K
B
110
Barings
North Carolina
$181K
VRS
111
Virginia Retirement Systems
Virginia
$174K -$78.4K -7,200 -30%
SCM
112
Stevens Capital Management
Pennsylvania
$165K +$45.5K +4,173 +35%
Balyasny Asset Management
113
Balyasny Asset Management
Illinois
$165K +$53.4K +4,900 +44%
BFM
114
Boothbay Fund Management
New York
$163K +$174K +15,941 New
NCCM
115
Nine Chapters Capital Management
New Jersey
$158K +$168K +15,400 New
Squarepoint
116
Squarepoint
New York
$156K -$30.5K -2,800 -16%
Los Angeles Capital Management
117
Los Angeles Capital Management
California
$155K +$165K +15,168 New
CAM
118
Capstone Asset Management
Texas
$153K -$1.2K -110 -0.7%
BPM
119
Bowling Portfolio Management
Ohio
$149K +$159K +14,585 New
NA
120
Navellier & Associates
Nevada
$147K +$156K +14,326 New
AG
121
Algert Global
California
$146K +$155K +14,266 New
AG
122
Aperio Group
California
$135K +$18.4K +1,690 +15%
NIT
123
NumerixS Investment Technologies
British Columbia, Canada
$135K +$144K +13,200 New
AIM
124
Acrospire Investment Management
Illinois
$131K +$91.2K +8,375 +190%
MSA
125
Mason Street Advisors
Wisconsin
$105K +$5.71K +524 +5%

SCLN Hedge Fund Activity: Q3 2016 in Review

151 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2016, worth a combined $396M — down 24% from $521M a quarter earlier.

Fund positioning in SCLN was balanced in Q3 2016: 22 funds opened new positions, 22 closed out, 62 added to existing stakes and 46 trimmed.

The largest buyer was Numeric Investors, adding an estimated $22.7M. The largest seller was Franklin Resources, cutting an estimated $35.4M.

  • 151 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $396M of Sciclone Pharmaceuticals Inc stock for Q3 2016, down 24% quarter-over-quarter.
  • 22 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2016 and 22 closed out, a net change of 0 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q3 2016 was Numeric Investors, an estimated $22.7M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q3 2016 was Franklin Resources, an estimated $35.4M sold.

Based on aggregated 13F filings for Q3 2016.